Methylated folate and folic acid are not the same thing. They are both forms of vitamin B9, but they differ in chemical structure, how your body processes them, and how effectively certain people can use them. Folic acid is a synthetic form created for supplements and fortified foods. Methylated folate (known as 5-MTHF or L-methylfolate) is the active form that already exists in your bloodstream and is ready for your cells to use.
How They Differ Chemically
Folic acid doesn’t exist in nature. It was engineered to be shelf-stable and inexpensive to manufacture, which is why it’s the form added to enriched breads, cereals, and most over-the-counter supplements. Natural folate in food is unstable during storage and cooking, so folic acid solved a practical problem for food fortification programs.
Methylated folate, by contrast, is the form your body actually uses. It’s the same molecule that circulates in your blood after your body finishes processing any type of folate you consume. When you see it on supplement labels, it appears under brand names like Quatrefolic or Metafolin, or listed as L-5-methyltetrahydrofolate.
Your Body Has to Convert Folic Acid
When you swallow folic acid, your body runs it through a multi-step conversion before it becomes useful. First, an enzyme in the liver reduces folic acid to dihydrofolate, then to tetrahydrofolate. From there, another enzyme converts it to an intermediate form, and finally a third enzyme (called MTHFR) reduces it to 5-MTHF, the active methylated folate your cells need.
That’s several enzymatic steps, each requiring a functioning enzyme. When you take methylated folate directly, you skip the entire conversion chain. The nutrient arrives in the form your body was going to make anyway.
Your liver can only process a limited amount of folic acid at one time. Whatever it can’t convert circulates in your blood as unmetabolized folic acid (UMFA). Since mandatory folic acid fortification began, most people carry some UMFA in their blood. The CDC notes that no confirmed health risks from UMFA have been found so far, but it does indicate that the conversion system has a ceiling.
Why Genetics Make This Personal
The final conversion step, handled by the MTHFR enzyme, is where genetics enter the picture. Two common gene variants affect how well this enzyme works, and they’re surprisingly widespread.
The C677T variant is the more impactful one. If you carry one copy (heterozygous), your MTHFR enzyme works at roughly 67% capacity. Two copies (homozygous) drops it to about 25% of normal activity. People with two copies tend to have lower blood levels of active folate and higher levels of homocysteine, an amino acid linked to cardiovascular risk when elevated.
The A1298C variant is milder. One copy reduces enzyme activity to about 83%, and two copies to about 61%. Unlike the C677T variant, A1298C doesn’t appear to raise homocysteine levels on its own.
Estimates suggest 40% to 60% of the population carries some form of these polymorphisms. For these individuals, taking methylated folate rather than folic acid bypasses a bottleneck their genetics created. Their bodies struggle to make enough active folate from folic acid, but methylated folate arrives pre-converted.
Bioavailability: Which Raises Blood Levels More?
The bioavailability comparison is less straightforward than supplement marketing suggests. Folic acid is actually very efficiently absorbed from the gut. In fact, the NIH assigns folic acid a higher “dietary folate equivalent” value than food folate: 1 microgram of folic acid taken with food counts as 1.7 micrograms of dietary folate equivalent, while 1 microgram of natural food folate counts as just 1.
Longer-term studies comparing folic acid and methylated folate supplements in healthy adults found that folic acid raised plasma folate levels 26% to 52% more than equivalent doses of methylated folate over periods of 16 to 24 weeks. This makes sense: folic acid is absorbed extremely well and, in people with normal MTHFR function, gets converted efficiently.
The advantage of methylated folate shows up specifically in people whose conversion is impaired. If your MTHFR enzyme is working at 25% capacity, the high absorption of folic acid matters less because the bottleneck is downstream. For these individuals, methylated folate delivers the active nutrient directly.
The B12 Masking Problem
One clinically important difference involves vitamin B12. Both folate deficiency and B12 deficiency cause the same type of anemia: your red blood cells become abnormally large and fewer in number. When someone with B12 deficiency takes high-dose folic acid, it can correct the anemia while leaving the B12 deficiency untreated. This is dangerous because B12 deficiency causes progressive nerve damage that continues silently once the visible warning sign (the anemia) disappears.
The mechanism involves how folic acid enters cells. Once inside, folic acid gets converted through a pathway that bypasses the step where B12 is needed, restoring normal blood cell production without fixing the underlying B12 problem. Researchers have also proposed that excess folic acid may deplete the transport protein that delivers B12 to tissues, potentially worsening neurological damage in people who are already B12-deficient.
Methylated folate, on the other hand, requires B12 to complete its role in cellular metabolism. When B12 is missing, methylated folate gets “trapped” in an unusable form. This means methylated folate is less likely to mask a B12 deficiency because it can’t easily work around the missing vitamin.
Pregnancy and Neural Tube Prevention
Folic acid supplementation around conception is one of the most well-established interventions in prenatal care, dramatically reducing the risk of neural tube defects like spina bifida. The evidence base for this recommendation was built almost entirely on folic acid, not methylated folate.
That said, some prenatal specialists now recommend methylated folate for women with a family history of neural tube defects or preterm births, since testing every woman for MTHFR variants before pregnancy isn’t practical. For women without these risk factors, standard folic acid in prenatal vitamins remains the default recommendation. Both forms effectively raise folate levels in most people, but methylated folate provides insurance against the possibility of impaired conversion.
Which Form Should You Choose?
For most people with normal MTHFR function, folic acid works well. It’s inexpensive, widely available, and has decades of safety and efficacy data behind it. The conversion process functions smoothly in people without relevant genetic variants.
Methylated folate becomes the more logical choice if you know you carry MTHFR variants (especially C677T homozygous), if you’ve had unexplained elevated homocysteine levels, or if you want to avoid any theoretical concerns about unmetabolized folic acid. It’s also worth considering if you’re at higher risk for B12 deficiency, since it won’t mask the anemia that serves as an early warning sign.
The price difference is real. Methylated folate supplements typically cost several times more than folic acid. Whether that premium is worth it depends on your individual genetics and risk profile. Without MTHFR testing, there’s no way to know for certain whether your body handles folic acid efficiently or struggles with that final conversion step.